GURU.Markets stock price, segment price, and overall market index valuation
The company's share price cbdMD Inc.
cbdMD is a producer of cannabidiol (CBD)-based products. Its stock price reflects the complex and uncertain regulatory environment for CBD in the US. Its chart tells the story of the battle for share in a crowded market and the search for a path to profitability.
Share prices of companies in the market segment - Pharma other
cbdMD, Inc. produces and sells a wide range of cannabidiol (CBD)-based products, from oils and capsules to cosmetics. We've classified it as "Other Pharmaceuticals." The chart below shows how the market views the competitive and poorly regulated CBD product sector.
Broad Market Index - GURU.Markets
cbdMD is a company that produces and sells a wide range of cannabidiol (CBD)-based products for health and wellness. It is a component of the GURU.Markets index. The chart below shows the market. See how this company's stock compares to the cannabis industry.
Change in the price of a company, segment, and market as a whole per day
YCBD - Daily change in the company's share price cbdMD Inc.
The daily price change of cbdMD, Inc. reflects the high volatility of the cannabis industry. The metric demonstrates sensitivity to changes in CBD legislation and competition in the crowded consumer goods market.
Daily change in the price of a set of shares in a market segment - Pharma other
cbdMD, Inc. produces and sells cannabidiol (CBD)-based products. The CBD market is highly competitive and faces regulatory uncertainty, creating significant volatility. The chart below shows average fluctuations in this sector, allowing one to assess how typical CBD market dynamics are for the industry.
Daily change in the price of a broad market stock, index - GURU.Markets
cbdMD is one of the leading brands in the cannabidiol (CBD) product market. The company's stock reflects both the industry's rapid growth and the high regulatory risks. The dynamics of this sector add a unique and volatile element to the overall market landscape.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization cbdMD Inc.
The year-over-year performance of cbdMD, Inc. is a story of the struggle for survival in the CBD market. Its market cap change over the past 12 months reflects the lack of clear FDA regulation, intense competition, and pricing pressure. Its valuation is a bet on whether a strong brand can survive the "crypto winter" in the cannabis industry.
Annual dynamics of market capitalization of the market segment - Pharma other
cbdMD, Inc. is a well-known brand in the cannabidiol (CBD) market. Its performance is heavily influenced by regulatory uncertainty surrounding CBD and intense competition. The chart below shows how these factors and brand-building efforts influence its volatile performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
cbdMD, a manufacturer and distributor of cannabidiol (CBD) products, operates in a rapidly growing, yet chaotic and poorly regulated market. Its year-over-year market capitalization reflects changing consumer and government attitudes toward CBD. The company is attempting to build a strong brand in a highly competitive environment.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization cbdMD Inc.
cbdMD is a well-known brand in the cannabidiol (CBD) product market. Its monthly performance reflects the complex regulatory landscape, fierce competition, and consumer trends in this industry. Quarterly sales reports are key.
Monthly dynamics of market capitalization of the market segment - Pharma other
cbdMD is a company that produces and markets a wide range of cannabidiol (CBD)-based products, from oils to cosmetics. Its success depends on the regulatory environment for CBD and its ability to stand out in a crowded market. The cannabis and CBD sector landscape reflects legal uncertainty and intense competition, which are the main challenges for cbdMD.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
cbdMD, Inc. is a well-known brand in the cannabidiol (CBD) product market. The company's stock price is weakly correlated with the broader market. It depends entirely on regulatory changes in the CBD industry, competition, and the brand's ability to maintain its share in this young and chaotic market.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization cbdMD Inc.
cbdMD, a company that produces and sells cannabidiol (CBD) products, operates in a gray and uncertain market. Its weekly stock price reflects news of potential FDA regulation of CBD, as well as intense competition and changing consumer preferences.
Weekly dynamics of market capitalization of the market segment - Pharma other
cbdMD produces and sells cannabidiol (CBD)-based products. Its business is entirely dependent on the evolving legal status of CBD and consumer demand. The chart clearly demonstrates how the company's stock performance is disconnected from the traditional consumer sector and tied to the specifics of the cannabis industry.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
cbdMD is a manufacturer of cannabidiol (CBD)-based products. Its shares are driven by news of legalization and regulation. The chart will show how much its performance is disconnected from the broader market and how it operates according to the industry's own, highly volatile laws.
Market capitalization of the company, segment and market as a whole
YCBD - Market capitalization of the company cbdMD Inc.
cbdMD's market capitalization is a barometer of the health of the cannabidiol (CBD) industry. The chart shows how investors value its brand and products in a crowded and unregulated market. Its sharp decline from its peaks reflects investor disillusionment with the industry, which has faced price competition and a lack of clear regulations from the FDA.
YCBD - Share of the company's market capitalization cbdMD Inc. within the market segment - Pharma other
cbdMD is one of the leading brands in the cannabidiol (CBD) product market. Its market share in the health and wellness sectors reflects its strong position. Its market capitalization reflects the strength of its brand, its extensive distribution network, and its ability to navigate a complex regulatory environment.
Market capitalization of the market segment - Pharma other
This graph shows the total value of the entire pharmaceutical and wellness sector. For cbdMD, a pioneer in the cannabidiol (CBD) market, this line is a map of legalization and acceptance. Its dynamics reflect how cannabis-based products are moving from the gray zone to the mainstream, creating a huge but competitive market for the company.
Market capitalization of all companies included in a broad market index - GURU.Markets
cbdMD is one of the leading companies in the cannabidiol (CBD) product market. Its market capitalization is a barometer of the CBD industry, its ups, downs, and regulatory challenges. It represents the market share of one of the most well-known, yet controversial, segments of the wellness market.
Book value capitalization of the company, segment and market as a whole
YCBD - Book value capitalization of the company cbdMD Inc.
cbdMD is a manufacturer and distributor of cannabidiol (CBD) products. Its book value comes from its production facilities, laboratories, and vast stockpiles of CBD oils, capsules, and cosmetics. This is the material foundation for the wellness industry. How has its value changed amid the CBD hype? The chart below shows.
YCBD - Share of the company's book capitalization cbdMD Inc. within the market segment - Pharma other
cbdMD, Inc. is a manufacturer and distributor of CBD products. Its business relies on production facilities where CBD is extracted and final products are created, as well as the logistics infrastructure for their distribution. The graph shows its share of the physical infrastructure of the cannabinoid industry.
Market segment balance sheet capitalization - Pharma other
cbdMD is a manufacturer of cannabidiol products. This sector, as the chart shows, is capital-intensive. cbdMD is a vertically integrated player with in-house production facilities to ensure the quality of its products.
Book value of all companies included in the broad market index - GURU.Markets
cbdMD's assets include production facilities and a distribution network for a wide range of cannabidiol (CBD)-based products, from oils to cosmetics. Its book value reflects its industrial potential in the competitive and poorly regulated CBD market.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - cbdMD Inc.
cbdMD is a company that produces and sells cannabidiol (CBD) products. Its market capitalization reflects the strength of its brand and its share of this young, fast-growing, yet highly competitive and poorly regulated market.
Market to book capitalization ratio in a market segment - Pharma other
cbdMD is a company that produces and sells cannabidiol (CBD) products. The CBD market is highly competitive and poorly regulated. The chart shows how investors evaluate its brand and ability to differentiate itself from hundreds of other players, as well as the regulatory risks.
Market to book capitalization ratio for the market as a whole
cbdMD produces and sells cannabidiol (CBD) products. The company's valuation depends on both its brand and distribution, as well as the regulatory environment. This chart provides an overview of investor sentiment for companies in this relatively new and rapidly growing, yet risky, consumer niche.
Debts of the company, segment and market as a whole
YCBD - Company debts cbdMD Inc.
cbdMD, a manufacturer of cannabidiol (CBD) products, operates in a young and underregulated market. The company is raising capital for marketing, distribution expansion, and research. This chart reflects the financial challenges associated with building a brand and business in a highly competitive environment with regulatory uncertainty.
Market segment debts - Pharma other
cbdMD is one of many companies operating in the crowded cannabidiol (CBD) product market. This chart shows how the company manages its capital amid intense competition, changing regulations, and marketing challenges as it strives to build a recognizable brand in this new and poorly regulated industry.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio cbdMD Inc.
cbdMD produces and markets a wide range of cannabidiol (CBD)-based products. Competing in this new and rapidly growing market requires significant investment in marketing, branding, and R&D. This chart shows how the company uses debt to fund its growth strategy and capture market share in hemp products.
Market segment debt to market segment book capitalization - Pharma other
cbdMD is a company that produces and sells cannabidiol (CBD)-based products. This market is characterized by high competition and an uncertain regulatory environment. This chart shows how the company's debt position compares to the overall market capitalization. It reflects the financial challenges of operating in this new and complex market.
Debt to book value of all companies in the market
cbdMD, Inc. produces and sells cannabidiol (CBD)-based products. This market is volatile, competitive, and faced with regulatory uncertainty. Using debt in this market can be extremely risky. This chart of total market debt highlights how cautious a company's financial policies must be in this industry.
P/E of the company, segment and market as a whole
P/E - cbdMD Inc.
cbdMD is a company that produces and sells a wide range of cannabidiol (CBD) products. This chart shows how investors value it in the crowded and poorly regulated CBD market. The valuation depends on brand awareness, sales growth, and regulatory changes.
P/E of the market segment - Pharma other
cbdMD, Inc. produces and sells cannabidiol (CBD)-based consumer products, such as oils, capsules, and cosmetics. This chart reflects the average valuation in the pharmaceutical and consumer sectors, but takes into account the high regulatory risks and uncertainty associated with the CBD product market.
P/E of the market as a whole
cbdMD, Inc. produces and markets a wide range of hemp-derived products containing cannabidiol (CBD) for humans and pets. This chart reflects overall investor interest in the cannabis sector. It helps understand whether YCBD's valuation reflects speculative interest in the industry or is supported by real growth metrics and brand loyalty in a competitive market.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company cbdMD Inc.
cbdMD, Inc. produces and markets a wide range of cannabidiol (CBD)-based products, from oils to cosmetics. The company's future depends on the regulatory environment and consumer demand for CBD products. This chart shows how investors view the CBD market outlook and the company's ability to build a strong brand in a highly competitive environment.
%20P%2FE%20cbdMD%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-cbdMD-Inc.&v=1772513680435 "Chart of the company's future (projected) P/E cbdMD Inc.")
Future (projected) P/E of the market segment - Pharma other
cbdMD, Inc. produces and sells cannabidiol (CBD) products such as oils, capsules, and cosmetics. The company operates in a rapidly growing but poorly regulated market. The chart compares cbdMD's future profitability expectations with the industry, helping to assess the market's perception of its prospects in a highly competitive and uncertain environment.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-other&v=1772513680445 "Future (projected) P/E graph of the market segment - Pharma other")
Future (projected) P/E of the market as a whole
cbdMD, Inc. produces and sells cannabidiol (CBD) products. The CBD market is rapidly growing but faces intense competition and regulatory uncertainty. This chart of overall risk appetite helps understand how investors view companies in the cannabis sector, which is still in its infancy.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513680489 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit cbdMD Inc.
cbdMD, Inc. produces and markets a wide range of cannabidiol (CBD)-based products, from oils to gummies. Profitability depends on brand strength and the company's ability to navigate a complex and evolving legal landscape. This chart shows the company's financial performance in the competitive and unregulated CBD market.
Profit of companies in the market segment - Pharma other
cbdMD, Inc. produces and markets a wide range of cannabidiol (CBD)-based products, from oils to cosmetics. The company is a recognizable brand in this young and competitive market. This chart shows overall profitability in the cannabis consumer goods sector, which is highly dependent on the regulatory environment and marketing.
Overall market profit
cbdMD, Inc. produces and sells cannabidiol (CBD)-based products. The company's growth depends on the expansion of the CBD product market and changes in legislation. This sector has its own unique drivers that are unrelated to the general economic cycles reflected in this chart. Key factors include regulation and consumer acceptance.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company cbdMD Inc.
cbdMD, Inc. produces and markets a wide range of cannabidiol (CBD)-based products. The company's future profitability depends on consumer demand for CBD products and regulatory uncertainty in the industry. This chart shows how analysts assess the company's prospects in a crowded and poorly regulated market.
%20profit%20of%20the%20company%20cbdMD%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-cbdMD-Inc.&v=1772513680726 "Graph of future (projected) profit of the company cbdMD Inc.")
Future (predicted) profit of companies in the market segment - Pharma other
cbdMD produces and markets a wide range of cannabidiol (CBD) products, from oils and capsules to cosmetics. The company's success depends on the regulatory environment and its ability to stand out in the crowded CBD product market. This chart shows profitability expectations for the pharmaceutical sector, providing context for assessing cbdMD's position in this emerging industry.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-other&v=1772513680737 "Graph of future (predicted) profits of companies in a market segment - Pharma other")
Future (predicted) profit of the market as a whole
cbdMD, Inc. produces and sells cannabidiol (CBD) products. The company's success depends on the regulatory environment and consumer demand for health and wellness products. This economic expectations chart reflects consumer confidence and willingness to spend on non-essential items.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513680822 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - cbdMD Inc.
cbdMD produces and sells cannabidiol (CBD)-based products. Revenue depends on consumer demand and the constantly evolving regulatory environment. This chart shows how investors view its brand and its ability to navigate the young and uncertain CBD industry.
P/S market segment - Pharma other
cbdMD is a leading brand in the cannabidiol (CBD) product market, offering a wide range of oils, capsules, and cosmetics. The company emphasizes quality, transparency, and consumer education in this rapidly growing but competitive industry. This chart displays the average revenue estimate for the sector, helping to assess how the market perceives the cbdMD brand.
P/S of the market as a whole
cbdMD, Inc. produces and markets a wide range of cannabidiol (CBD)-based products, from oils to cosmetics. This chart, showing average revenue estimates, helps gauge investor sentiment toward the manufacturer in the crowded and still-emerging CBD market, with its regulatory uncertainty.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company cbdMD Inc.
cbdMD, Inc. produces and markets a wide range of cannabidiol (CBD)-based products in the United States. The company's future revenue depends on consumer demand and the regulatory environment for CBD products. This chart, which ranks the company by projected sales, illustrates how investors view the prospects of this young and competitive market, as well as the strength of the cbdMD brand.
%20P%2FS%20cbdMD%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-cbdMD-Inc.&v=1772513680889 "The graph of the company's future (projected) P/S cbdMD Inc.")
Future (projected) P/S of the market segment - Pharma other
cbdMD produces and markets a wide range of cannabidiol (CBD)-based products, from oils to gummies. This chart compares the company's estimated future revenue with other cannabis market players. It reflects investor expectations regarding CBD market growth, the strength of the cbdMD brand, and its ability to navigate the complex regulatory environment.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20other&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-other&v=1772513680895 "Future (projected) P/S market segment graph - Pharma other")
Future (projected) P/S of the market as a whole
cbdMD produces and markets a wide range of cannabidiol (CBD) products in the United States. The company's success depends on the growth of the CBD market and regulatory certainty. This graph of investor expectations reflects their view of the cannabis industry and consumer demand for wellness products, despite legal uncertainties.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513680926 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales cbdMD Inc.
The graph illustrates cbdMD, Inc.'s revenue from sales of a wide range of cannabidiol (CBD) products, including oils, capsules, and cosmetics. Revenue trends reflect consumer demand for CBD products, as well as the high level of competition and regulatory uncertainty in this emerging market.
Sales of companies in the market segment - Pharma other
cbdMD, Inc. produces and sells a wide range of cannabidiol (CBD)-based products. Its sales breakdown shows the proportion of revenue generated by different product categories (oils, capsules, cosmetics) and distribution channels (online, retail). This reflects its strategy to reach a broad audience in the competitive CBD market.
Overall market sales
cbdMD, Inc. produces and sells cannabidiol (CBD)-based products. The company operates in a rapidly growing but still-emerging industry. Its success depends on the regulatory environment and changing consumer attitudes toward hemp products. This chart of overall consumer activity helps assess how this new category of wellness products is gaining market share.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company cbdMD Inc.
cbdMD, Inc. produces and markets a wide range of cannabidiol (CBD)-based products, including oils, capsules, and cosmetics. Sales growth depends on consumer demand for CBD products and the regulatory environment. This chart shows analyst forecasts for the cannabidiol market and the company's ability to compete under its brand.
%20sales%20of%20the%20company%20cbdMD%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-cbdMD-Inc.&v=1772513680978 "Schedule of future (projected) sales of the company cbdMD Inc.")
Future (projected) sales of companies in the market segment - Pharma other
cbdMD, Inc. produces and markets a wide range of cannabidiol (CBD)-based products. This chart shows the outlook for the consumer health products market. How is changing regulation and consumer acceptance of CBD impacting analysts' growth expectations for this young market? This chart reflects general trends.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-other&v=1772513680995 "Schedule of future (projected) sales of companies in the market segment - Pharma other")
Future (projected) sales of the market as a whole
cbdMD produces and sells cannabidiol (CBD)-based consumer products. The CBD market is new and highly dependent on the regulatory environment and changing consumer preferences. While this overall economic activity pattern impacts discretionary spending, cbdMD is more concerned with legislative changes and growing awareness of CBD products.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513681016 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality cbdMD Inc.
cbdMD, Inc. produces and markets a wide range of cannabidiol (CBD)-based products. This chart illustrates how the company operates in the crowded and poorly regulated CBD market. Its profitability depends on brand strength, marketing effectiveness, and its ability to navigate the complex and evolving regulatory landscape surrounding hemp products.
Market segment marginality - Pharma other
cbdMD, Inc. produces and sells cannabidiol (CBD)-based consumer products. The company's profitability depends on the strength of its brand, marketing effectiveness, and the complex, ever-changing regulatory environment for hemp products. This metric reflects how the company operates in this new and competitive industry.
Market marginality as a whole
cbdMD, Inc. produces and sells cannabidiol (CBD)-based products. The company operates in a young and competitive market that is highly vulnerable to regulatory changes. This overall profitability chart reflects the state of the consumer sector. During periods of economic uncertainty, demand for wellness products can be volatile.
Employees in the company, segment and market as a whole
Number of employees in the company cbdMD Inc.
cbdMD, Inc. produces and sells cannabidiol (CBD)-based products. The number of its personnel involved in production, marketing, and distribution reflects the scale of its operations. This chart shows how the company is adapting to the complex regulatory environment and highly competitive CBD consumer products market.
Share of the company's employees cbdMD Inc. within the market segment - Pharma other
cbdMD produces and markets a wide range of cannabidiol (CBD)-based products. Production, marketing, and distribution in this young and highly regulated industry require a significant workforce. This chart shows the company's labor market share, reflecting its scale as one of the leading brands in the consumer CBD market.
Number of employees in the market segment - Pharma other
cbdMD, Inc. produces and markets a wide range of cannabidiol (CBD)-based products, including oils, capsules, and cosmetics. The chart reflects overall employment in the pharmaceutical industry. The company operates in the rapidly growing, yet competitive and poorly regulated CBD market, striving to differentiate itself through quality and branding.
Number of employees in the market as a whole
cbdMD, Inc. produces and sells cannabidiol (CBD)-based products. Its business sits at the intersection of consumer goods, wellness, and evolving legislation. This chart shows the big picture, and cbdMD is an example of a company in a new, rapidly growing industry whose employment dynamics are driven by legalization and market acceptance of its products.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company cbdMD Inc. (YCBD)
cbdMD, Inc. is a leading brand in the cannabidiol (CBD) product market. It's a consumer goods company where branding and distribution play a key role. This chart shows how the market values their brand. It reflects the market value per employee, which is a measure of brand strength and the effectiveness of their marketing and production operations.
%20of%20the%20company%20cbdMD%20Inc.%20(YCBD)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-cbdMD-Inc.-YCBD&v=1772513681117 "Chart of market capitalization per employee (in thousands of dollars) of the company cbdMD Inc. (YCBD)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma other
cbdMD (YCBD) produces and sells a wide range of cannabidiol (CBD)-based products. In the cannabis industry, this metric can reflect the strength of the brand and distribution network. Exceeding the industry average may indicate that cbdMD has built a recognizable brand that is trusted by consumers, allowing it to maintain a premium price.
%20by%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-other&v=1772513681129 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma other")
Market capitalization per employee (in thousands of dollars) for the overall market
cbdMD produces and sells cannabidiol (CBD)-based products. In this young and competitive industry, value is created by brand and quality. This metric reflects how the market evaluates a company's ability to stand out from hundreds of competitors, build a loyal audience, and effectively manage its supply chain.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513681154 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company cbdMD Inc. (YCBD)
cbdMD is one of the leading brands in the cannabidiol (CBD) product market—oils, capsules, and cosmetics. This chart illustrates the profitability of this highly competitive market. Profit per employee is a result of brand strength, marketing effectiveness, and the ability to maintain margins in the consumer goods sector.
%20Chart%20cbdMD%20Inc.%20(YCBD)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-cbdMD-Inc.-YCBD&v=1772513681158 "Company Profit Per Employee (in thousands of dollars) Chart cbdMD Inc. (YCBD)")
Profit per employee (in thousands of dollars) in the market segment - Pharma other
cbdMD, Inc. produces and sells cannabidiol (CBD)-based products. In the rapidly growing but competitive CBD market, productivity per employee depends on the strength of the brand, marketing, and distribution. This chart allows you to evaluate how successfully the company generates profits compared to many other players in the industry.
%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-other&v=1772513681190 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma other")
Profit per employee (in thousands of dollars) for the market as a whole
cbdMD is a company that produces and sells cannabidiol (CBD) consumer products—oils, capsules, and cosmetics. It's a consumer packaged goods (CPG) business operating in a "gray" regulatory zone. This chart helps understand how profitable a brand is per employee in the competitive CBD industry, which requires marketing and production.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513681207 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee cbdMD Inc. (YCBD)
cbdMD, Inc. produces and sells cannabidiol (CBD)-based products. This chart shows their performance in a competitive market. The increase in revenue per employee can be attributed to brand strength, expansion of the distribution network, and optimization of production and marketing costs.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-cbdMD-Inc.-YCBD&v=1772513681211 "Sales chart per company employee cbdMD Inc. (YCBD)")
Sales per employee in the market segment - Pharma other
cbdMD, Inc. (YCBD) is a well-known brand in the US that produces and sells cannabidiol (CBD) products, including oils, capsules, and cosmetics. This chart shows the average output in the sector. For YCBD, this is an indicator of how effective their brand, production, and marketing are in the highly competitive and unregulated CBD market.
Sales per employee for the market as a whole
cbdMD is a leader in the CBD (cannabidiol) consumer goods market. They sell oils, capsules, and cosmetics. It's a classic CPG (consumer packaged goods) business. This indicator shows how effective their brand, marketing, and e-commerce platform are in generating sales.
Short shares by company, segment and market as a whole
Shares shorted by company cbdMD Inc. (YCBD)
cbdMD (YCBD) is one of many companies attempting to build a brand on the CBD (cannabidiol) boom. The market proved oversaturated and low-margin. This chart tracks short positions. Shorts reflect a bet that the company will be unable to withstand the competition and that consumer interest in CBD is waning.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-cbdMD-Inc.-YCBD&v=1772513681260 "Short Shares Chart for the Company cbdMD Inc. (YCBD)")
Shares shorted by market segment - Pharma other
cbdMD (YCBD) is a leading company in the cannabidiol (CBD) product market, including oils, capsules, and cosmetics. This chart shows the total short position in the cannabis sector. It reflects investor pessimism about the industry due to the lack of federal regulation in the US and fierce competition.
Shares shorted by the overall market
cbdMD is one of many cannabidiol (CBD) product manufacturers. This chart illustrates the overall market pessimism. The CBD market is overcrowded, lacks clear regulations, and investors are tired of the hype. In times of fear, they see cbdMD as just another unprofitable company in a highly competitive and murky market.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator cbdMD Inc. (YCBD)
cbdMD is a leader in the crowded cannabidiol (CBD) product market. Its business depends on marketing and regulation. This indicator measures the "temperature" of the CBD hype. It heated up during the legalization wave, but has now cooled, reflecting intense competition and uncertainty from the FDA.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-cbdMD-Inc.-YCBD&v=1772513681333 "RSI 14 indicator chart for the company's stock cbdMD Inc. (YCBD)")
RSI 14 Market Segment - Pharma other
cbdMD (YCBD) is a well-known brand in the crowded market of cannabidiol (CBD) products—oils, supplements, and cosmetics. This chart measures collective sentiment in the Pharma/Cannabis sector. It shows when the entire industry is overheated by legalization news or oversold due to regulatory hurdles, which is the backdrop for YCBD.
RSI 14 for the overall market
For cbdMD, which operates in the CBD sector, this chart is an indicator of appetite for hype. During periods of market euphoria, investors are willing to generously fund speculative "conceptual" sectors. In moments of panic, capital flees unprofitable companies with high regulatory risks, and companies risk being left without funds.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast YCBD (cbdMD Inc.)
cbdMD is a leading American brand, producing and selling a wide range of CBD (cannabidiol) consumer products, from oils to gummies. This chart shows the speculative average price target from analysts, reflecting their view of the brand's growth and the high regulatory risks pending FDA decisions.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-YCBD-cbdMD-Inc.&v=1772513681465 "A chart showing analyst consensus forecasts for the expected stock price. YCBD (cbdMD Inc.)")
The difference between the consensus estimate and the actual stock price YCBD (cbdMD Inc.)
cbdMD is one of the leading US brands in the consumer cannabidiol (CBD) market. The company sells oils, capsules, and gummies. This chart illustrates the analyst community's opinion on the company's future. It measures the distance between the stock price and the target, reflecting their view of the complex and unregulated CBD market.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-YCBD-cbdMD-Inc.&v=1772513681506 "A chart showing the difference between the consensus forecast and the actual stock price. YCBD (cbdMD Inc.)")
Analyst consensus forecast for stock prices by market segment - Pharma other
cbdMD (YCBD) is a leader in the US CBD (cannabidiol) market. The company sells hemp-based oils, supplements, and cosmetics. This chart shows general expectations for the pharmaceutical sector. It reflects whether experts believe the oversaturated and unregulated CBD market will grow or whether they expect it to consolidate.
Analysts' consensus forecast for the overall market share price
cbdMD is one of the leading American brands producing and selling cannabidiol (CBD) products, including oils, gummies, and creams. This chart shows the overall risk appetite in the market. For cbdMD, which operates in a volatile sector dependent on legalization (FDA), overall market optimism is important, but regulatory news carries far more weight than general sentiment.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index cbdMD Inc.
cbdMD is a veteran of the CBD boom. They were one of the leaders in the direct-to-consumer (D2C) market (e-commerce) selling CBD oils and gummies. Now the hype has died down. This chart summarizes their battle for survival. It reflects their (falling) sales, their cash burn (on marketing), and their struggle in the FDA's regulatory gray area.
AKIMA Market Segment Index - Pharma other
cbdMD (YCBD) is one of the most recognizable direct-to-consumer (DTC) brands in the cannabidiol (CBD) market. The company produces and sells a wide range of products—from oils and gummies to cosmetics and pet products—with a strong focus on marketing and quality. This chart shows the average index for the segment, helping investors assess how successful this CBD brand is compared to the average.
The AKIM Index for the overall market
cbdMD is a brand of cannabidiol (CBD)-based products for health and wellness (for both humans and animals). This chart, which reflects the market average, provides a macro backdrop. It helps assess how CBD, operating in a saturated and unregulated CBD market, compares to the overall macroeconomic situation.
